abc Non-ribosomal peptides contain an array of amino acid building blocks that can present challenges for the synthesis of important intermediates. Here, we report the synthesis of glycopeptide antibiotic (GPA) thioester peptides that retains the crucial stereochemical purity of the terminal phenylglycine residue, which we show is essential for the enzymatic GPA cyclisation cascade.Non-ribosomal peptide synthesis is central to the biosynthesis of many compounds of medical importance, including a large number of antibiotics. [1][2][3][4] Due to the modular structure of nonribosomal peptide synthetases (NRPSs) -comprising repeating domains performing specific catalytic functions -and their non-dependence on the ribosome, NRPS assembly lines are able to synthesise peptides from a wide range of amino acids.
1,3This feature, combined with the extensive incorporation of (D)-amino acids and large range of further structural modifications, contribute to the extensive diversity of natural NRPS-peptides.
1,2Given the complexity of many of these compounds that are of medical interest -such as the glycopeptide antibiotics ( Fig. 1), with vancomycin and teicoplanin as representative members -there is a need to characterise NRPS biosynthesis in order to explore the possibilities for compound development through redesigning the corresponding biosynthetic machinery. [1][2][3][4] In this regard, GPAs are perfect examples: total synthesis is highly challenging, meaning that all GPAs in clinical use stem from bacterial production in vivo and modified GPAs generated via total synthesis are not always accessible for the use in clinics. 4,5 The main reasons for this synthetic complexity are the high content of racemisation-prone phenylglycine residues as well as the highly crosslinked structure of GPAs (vancomycin:, which is formed by cytochrome P450 (Oxy) enzymes that interact with the unique NRPS domain found in GPA biosynthesis, the X-domain. 4,6,7 Fig. 1 GPA cyclisation in vitro is enabled by diastereomerically pure phenylglycine thioester peptides: teicoplanin seq. 5: R 1 = 4-Hpg; R 2 = Cl; R 3 = 3,5-Dpg; pekiskomycin seq. 6: R 1 = CH 3 ; R 2 = H; R 3 = Glu; actinoidin seq. 7: R 1 = 4-Hpg; R 2 = H; R 3 = Phe; vancomycin seq. 8: R 1 = Leu; R 2 = Cl; R 3 = Asn. PCP -peptidyl carrier protein domain, X -Oxy recruitment domain, A tei -OxyA from the teicoplanin system, B van -OxyB from the vancomycin system.